Award
NIH Reporter #3UM1CA186691-09S1
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
Recipient
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
Awarded
June 16, 2026
Identifier
3UM1CA186691-09S1
Award to The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies by the National Cancer Institute to support clinical trials and training in anticancer drug development.
Description
The project is funded by the National Cancer Institute (NCI) under award number 3UM1CA186691-09S1. The project aims to support high-quality clinical trials evaluating novel anticancer agents. It involves multiple cancer centers and aims to train the next generation of investigators. The project is part of the ETCTN network and aims to enhance drug development efforts.